Sofia Carlsson
I am an epidemiologist with a strong interest in LADA (latent autoimmune diabetes in adults), adult-onset type 1 diabetes, and early-onset type 2 diabetes. My research aims to expand knowledge on the
About me
My research aims to expand knowledge on the causes and consequences of diabetes, with a particular focus on understudied forms such as LADA (latent autoimmune diabetes in adults), adult-onset type 1 diabetes, and early-onset type 2 diabetes.
Research
My work aims to expand knowledge on causes and consequences of autoimmune diabetes in adults including both LADA and type 1 diabetes and early-onset type 2 diabetes. An important cornerstone of this work is the ESTRID study (epidemiological study of risk factors for LADA-latent autoimmune diabetes in adults and type 2 diabetes) https://ki.se/en/imm/research/units-at-imm/unit-of-epidemiology/estrid, an ongoing multicenter study conducted at IMM. ESTRID is the largest and most detailed study of LADA to date and will provide unique opportunities to study the influence of both environmental and genetic factors on the disease onset and prognosis.
We also use nationwide register data and combine traditional cohort designs with family-based designs to strengthen causal inference. The overall aim of my research is to identify modifiable risk factors that can be used to prevent LADA, type 1 diabetes and early-onset type 2 diabetes and factors contributing to poor prognosis to inform secondary prevention.
Teaching
I have more than 15 years of experience teaching epidemiological methods (over 1, 000 teaching hours) at Karolinska Institutet, at both undergraduate and postgraduate levels. I served as course leader for a five-week course in Epidemiological methods within the Master’s Programme in Public Health at KI from 2013 to 2022.
Articles
- Article: JOURNAL OF AUTOIMMUNITY. 2026;161:103576Sorgjerd EP; Hals IK; Lonnum BEE; Edstorp J; Ahlqvist E; Carlsson S; Grill V
- Article: NPJ PARKINSONS DISEASE. 2026;12(1):127Vincze K; Szwajda A; Ploner A; Karlsson R; Kang X; Tang B; Qin C; Domenighetti C; Sugier P-E; Ashok Kumar Sreelatha A; Schulte C; Portugal B; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol J-C; Chartier-Harlin M-C; Mutez E; Brockmann K; Deutschlander AB; Burbulla LF; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; Van de Warrenburg BP; Bloem BR; Toft M; Pihlstrøm L; Correia Guedes L; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Ran C; Belin AC; Puschmann A; Clarke CE; Morrison KE; Tan M; Krainc D; Farrer MJ; Landoulsi Z; Kruger R; Gasser T; Elbaz A; Sharma M; Pedersen NL; Carlsson S; Hägg S; Wirdefeldt K; Comprehensive Unbiased Risk Factor Assessment for ; Domenighetti C; Sugier P-E; Ashok Kumar Sreelatha A; Schulte C; Portugal B; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol J-C; Chartier-Harlin M-C; Mutez E; Brockmann K; Deutschlander AB; Burbulla LF; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Nakayama A; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; Van de Warrenburg BP; Bloem BR; Toft M; Pihlstrøm L; Correia Guedes L; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Ran C; Belin AC; Puschmann A; Clarke CE; Morrison KE; Tan M; Krainc D; Farrer MJ; Landoulsi Z; Kruger R; Gasser T; Elbaz A; Sharma M; Wirdefeldt K
- Article: DIABETOLOGIA. 2026;69(5):1226-1236Lampousi A-M; Zeng J; Lofvenborg JE; Carlsson S; Ludvigsson J
- Article: CANCERS. 2026;18(9):1428Zhang Z; Carlsson S; Hammar N; Acedo P; Russell B; Kordasti S; Sarker D; Hemelrijck MV; Santaolalla A
- Article: LANCET DIABETES & ENDOCRINOLOGY. 2026;14(3):223-232Bjarko VV; Wolford BN; Haug EB; Stene LC; Carlsson S; Langhammer A; Birkeland KI; Berg TJ; Sorgjerd EP; Lyssenko V; Brumpton BM; Vie GA; Asvold BO
- Article: METABOLOGIA. 2026;2(1):2Keysendal E; Carlsson S; Lampousi A-M; Hampe CS; Huerta JM; Kerrison N; Nilsson PM; Pala V; Schulze MB; Sharp SJ; Rolandsson O; Wareham NJ
- Article: EUROPEAN JOURNAL OF PUBLIC HEALTH. 2025;35(6):1258-1263Carlsson S; Andersson T; Jansson S; Nystrom T; Rolandsson O; Wei Y
- Article: CELL REPORTS MEDICINE. 2025;6(11):102454Zhao A; Wei Y; Kontidou E; Mahdi A; Jannig PR; Torstensson S; Jiang H; Larsson A; Collado A; Humoud R; Grunler J; Ersga D; Esen BO; Zheng X; Lu H; Lindgren E; Risal S; Zhao J; Stener-Victorin E; Sorensen HT; Pedersen L; Pernow J; Zhou Z; Carlsson S; Catrina S-B; Deng Q
- Article: CLINICAL NUTRITION. 2025;54:153-161Lampousi A-M; Ahlqvist E; Alfredsson L; Edstorp J; Di Giuseppe D; Grill V; Lofvenborg JE; Padyukov L; Tuomi T; Asvold BO; Carlsson S
- Article: EUROPEAN HEART JOURNAL. 2025;46(38):3776-3786Wei Y; Andersson T; Tuomi T; Nystrom T; Carlsson S
- Article: DIABETIC MEDICINE. 2025;42(10):e70106Riise HKR; Haugstvedt A; Igland J; Wilhelmsen-Langeland A; Softeland E; Hermann M; Carlsson S; Skinner TC; Asvold BO; Iversen MM
- Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY. 2025;40(7):845-857Amadou C; Wei Y; Tuomi T; Feychting M; Carlsson S
- Article: NATURE COMMUNICATIONS. 2025;16(1):5327Wei Y; Andersson T; Liu S; Feychting M; Kuja-Halkola R; Carlsson S
- Article: NEUROLOGY. 2025;104(5):e213372Tomson T; Andersson T; Carlsson S; Sveinsson O
- Article: DIABETOLOGY & METABOLIC SYNDROME. 2025;17(1):62Riise HKR; Haugstvedt A; Igland J; Graue M; Softeland E; Hermann M; Carlsson S; Skinner TC; Asvold BO; Iversen MM
- Article: DIABETOLOGIA. 2025;68(2):331-341Santoso C; Wei Y; Ahlqvist E; Tuomi T; Carlsson S
- Article: DIABETOLOGIA. 2025;68(1):69-81Edstorp J; Rossides M; Ahlqvist E; Alfredsson L; Askling J; Di Giuseppe D; Grill V; Sorgjerd EP; Tuomi T; Asvold BO; Carlsson S
- Article: EPILEPSY & BEHAVIOR. 2024;161:110106Melin S; Tomson T; Sveinsson O; Andersson T; Carlsson S; Rück C; Wirdefeldt K
- Article: BMJ OPEN DIABETES RESEARCH & CARE. 2024;12(6):e004493Bjarko VV; Haug EB; Langhammer A; Ruiz PL-D; Carlsson S; Birkeland KI; Berg TJ; Sorgjerd EP; Lyssenko V; Asvold BO
- Article: LANCET REGIONAL HEALTH-EUROPE. 2024;46:101056Sun J; Yao J; Olen O; Halfvarsson J; Bergman D; Ebrahimi F; Carlsson S; Ludvigsson J; Ludvigsson JF
- Show more
All other publications
- Review: DIABETOLOGIA. 2026;69(11):3131-3147Stener-Victorin E; Carlsson S; Hagstrom H; Taebnia N
- Review: DIABETOLOGIA. 2026;:1-20Carlsson S; Tuomi T; Lampousi A-M
- Review: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2025;54(8):942-953Carlsson S; Beck M; Bergstrom A; Dreij K; Ganguly K; Kippler M; Laguzzi F; Leander K; Lu D; Palmberg L; Upadhyay S; Zettergren A; Pershagen G
- Conference publication: DIABETOLOGIA. 2025;68:S4Wei Y; Nystrom T; Andersson T; Misra S; Tuomi T; Carlsson S
- Conference publication: DIABETOLOGIA. 2025;68:S186-S187Keysendal E; Ahlqvist E; Asvold BO; Edstorp J; Tuomi T; Bjarko VV; Carlsson S
- Review: ECLINICALMEDICINE. 2025;83:103222Zeng J; Beck M; Barouti AA; Loefvenborg JE; Carlsson S; Lampousi A-M
- Conference publication: EPILEPSIA. 2024;65:22Melin S; Tomson T; Sveinsson O; Carlsson S; Andersson T; Wirdefeldt K
- Conference publication: DIABETOLOGIA. 2024;67:S151-S152Lampousi A-M; Ahlqvist E; Alfredsson L; Askling J; Edstorp J; Di Giuseppe D; Grill V; Lofvenborg JE; Padyukov L; Sorgjerd EP; Tuomi T; Asvold BO; Carlsson S
- Conference publication: DIABETOLOGIA. 2024;67:S48Wei Y; Andersson T; Tuomi T; Nystrom T; Carlsson S
- Review: ADVANCES IN NUTRITION. 2024;15(5):100211Lampousi A-M; Lundberg T; Lofvenborg JE; Carlsson S
- Letter: DIABETOLOGIA. 2024;67(3):567-568Grill V; Sorgjerd E; Hals I; Carlsson S
- Conference publication: DIABETOLOGIA. 2023;66(SUPPL 1):S177-S178Edstorp J; Rossides M; Ahlqvist E; Alfredsson L; Rasouli B; Tuomi T; Carlsson S
- Conference publication: DIABETOLOGIA. 2023;66(SUPPL 1):S174-S175Lampousi A-M; Lundberg T; Lofvenborg JE; Carlsson S
- Conference publication: DIABETOLOGIA. 2023;66(SUPPL 1):S170Wei Y; Carlsson S
- Meeting abstract: LANCET GLOBAL HEALTH. 2023;11:S1Wei Y; Zhan Y; Carlsson S
- Conference publication: EPILEPSIA. 2022;63:151-152Melin S; Wirdefeldt K; Sveinsson O; Andersson T; Carlsson S; Tomson T
- Conference publication: DIABETOLOGIA. 2022;65(SUPPL 1):S114Wei Y; Ahlqvist E; Andersson T; Tuomi T; Carlsson S
- Conference publication: DIABETOLOGIA. 2022;65(SUPPL 1):S153Edstorp J; Ahlqvist E; Alfredsson L; Grill V; Rasouli B; Sorgjerd EP; Tuomi T; Asvold B; Carlsson S
- Conference publication: DIABETOLOGIA. 2022;65(SUPPL 1):S150-S151Lampousi A-M; Carlsson S; Lofvenborg JE
- Review: FRONTIERS IN ENDOCRINOLOGY. 2022;13:917850Carlsson S
- Show more
Grants
- Early-onset type 2 diabetes, a growing threat to public health with a strong social gradientSwedish Research Council for Health Working Life and Welfare1 January 2026
- Swedish Research Council for Health Working Life and Welfare1 January 2026 - 31 December 2029Research problem and specific questionsType 2 diabetes (T2D) is a common, chronic disease that increases the risk of cardiovascular disease and shortens life expectancy. T2D was formerly known as “old-age diabetes” but is now increasingly affecting adolescents and young adults (<40 years). In Sweden, the prevalence of early-onset T2D doubled between 2006 and 2021. The risk is highest among people with a foreign origin or low education and is increasing fastest in young women. This is an alarming trend because the earlier the disease develops, the higher the risk of serious complications and shortened life expectancy. Moreover, developing T2D at a young age may negatively affect family formation, professional life and pregnancy outcomes. Preventing early-onset T2D requires knowledge of the factors influencing the risk of developing the disease, and factors that increase the risk of complications and reduced life chances for those affected. International research on early-onset T2D is limited, and Swedish research almost non-existent. The aim of this project is to fill key knowledge gaps regarding the risk factors and consequences of early-onset T2D. Specifically, we will:RISK FACTORS: elucidate heritability and identify risk factors (pre- and perinatal factors, individual and contextual socioeconomic factors, ethnic origin, childhood/adolescent diseases, lifestyle factors).CONSEQUENCES: study mortality, cardiovascular disease, pregnancy outcomes and socio-economic consequences and identify prognostic factors (inadequate treatment, mental and somatic co-morbidity, glucose control and metabolic risk factors, lifestyle and socio-economic and demographic factors).Data and methodsWe have created a database consisting of the entire Swedish population and collected information from nine national registries over a 40-year period. This allows us to identify all those who developed T2D diabetes in Sweden since the 1990s, map exposures before diagnosis and follow their prognosis. We have identified kinship ties within the cohort and can thus combine traditional cohort design with family-based design and compare people who developed T2D with their siblings without diabetes with respect to possible risk factors and different health and socioeconomic outcomes. In this way, confounding can be minimized. We will also conduct focus group interviews with young people with T2D to generate hypotheses and deepen the interpretations of the results obtained.Societal relevance and utilisationT2D in young people is a significant public health threat, with a strong social gradient. The proposed project is the most comprehensive of its kind and has the potential to significantly increase knowledge about T2D and its determinants and consequences among young people in Sweden. The results can be used to identify vulnerable groups in need of targeted interventions, improve primary and secondary prevention and inform policy makers. Thereby, the study can contribute to improved public health and reduced health inequalities. The results will be communicated in the form of scientific articles and via reports and seminars aimed at authorities responsible for public health and care such as the Public Health Agency of Sweden and the National Board of Health and Welfare, as well as regional public health and healthcare planners and providers. We will also publish in professional journals to reach the clinical profession and communicate with patient organizations, such as the Swedish Diabetes Association and write articles in patient magazines.Plan for project realisationThe project is being carried out at Karolinska Institutet by a team with expertise in all aspects of the project (epidemiology, biostatistics, sociology, obstetrics, endocrinology and cardiology). Most of the data is available, and preliminary analyses show that the feasibility is high. Funding is sought for analysis, report writing, focus group interviews and communication of research results.
- Time trends in the genetic and environmental contributions to type 1 diabetes in Sweden 1982–2020Barndiabetesfondens1 May 2025 - 30 April 2026
- Swedish Research Council1 January 2023 - 31 December 2026Diabetes is a chronic disease affecting 1/5 swedes during their lifetime, associated with CVD and reduced life expectancy. With a finer classification of diabetes, opportunities arise for better assessment of factors influencing onset and prognosis, which may lead to improved prevention. This project involves subtypes within the broad categories T1D and T2DLADA– a common form of autoimmune diabetes, newly proposed subtypes of T2D- including a severe insulin resistant and a severe insulin deficient type, and adult onset T1D. We aim to provide new knowledge on the interplay environmental vs. genetic factors influences in the aetiology of these largely unexplored subtypes of diabetes. To this aim, we are conducting the world´s largest study of LADA, the ESTRID-study, with incident cases of LADA and T2D subtypes and clinical, genetic and environmental information. The Norwegian HUNT-study, European Epic-InterAct and UK biobank, which includes adult onset T1D, will be used for extensions and replication. We will use Mendelian Randomization design for causal inference. ESTRID and HUNT are linked to national registers allowing us to follow patients from diagnosis and assess the prognostic role of clinical, genetic and lifestyle factors. The aim is to identify factors increasing the risk of autoimmune diabetes in adults and different forms of T2D and factors contributing to poor prognosis. Such knowledge is central future efforts to prevent diabetes and its consequences.
- Swedish Research Council for Health Working Life and Welfare1 January 2021 - 31 December 2024
- Infections, antibiotics, tobacco, genetic susceptibility and risk of Latent autoimmune diabetes in adults and type 2 diabetesNovo Nordisk Foundation1 January 2020 - 31 December 2022
- Novo Nordisk Foundation1 January 2019 - 31 December 2019
- Swedish Research Council1 January 2019 - 31 December 2022
- Swedish Research Council for Health Working Life and Welfare1 January 2019 - 31 December 2022
- LADA-LATENT AUTOIMMUNE DIABETES IN ADULTS, RISK FACTORS AND PROGNOSISNovo Nordisk Foundation1 January 2018 - 31 December 2020
- Swedish Research Council for Health Working Life and Welfare1 October 2017 - 30 September 2021
- Novo Nordisk Foundation1 January 2017 - 31 December 2017
- INFLUENCE OF DIET ON THE RISK OF LADA (LATENT AUTOIMMUNE DIABETES IN ADULTS) AND TYPE 2 DIABETESNovo Nordisk Foundation1 January 2017 - 1 January 2018
- Novo Nordisk Foundation1 January 2016 - 31 December 2016
- Swedish Research Council for Health Working Life and Welfare1 December 2015 - 30 September 2016
- Swedish Research Council1 January 2015 - 31 December 2018
- Swedish Research Council for Health Working Life and Welfare1 December 2012 - 31 December 2015
- Swedish Research Council1 January 2010 - 31 December 2012
Employments
- Senior Lecturer, Institute of Environmental Medicine, Karolinska Institutet, 2015-
Degrees and Education
- Docent, Karolinska Institutet, 2008
- Doctor Of Philosophy, Institute of Environmental Medicine, Karolinska Institutet, 2003
- Licentiate Degree, Institute of Environmental Medicine, Karolinska Institutet, 1999